JAK2 and Chronic Eosinophilic Leukemia, Not Otherwise Specified: The results showed that the phosphorylation levels of JAK2, Stat3, and Stat5 were significantly decreased in both F/P(+) CEL patients and EOL-1 cells after treatment with Imatinib.